Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.
Stocks to Buy
Blue state California shocked the nation by overturning its assault weapons ban. This will likely have big implications for stocks to buy.
Investors should hold positions in these seven stocks in order to capitalize on America's growing supply-chain issues moving forward.
Chamath Palihapitiya is a controversial figure and some folks are disillusioned with SPAC's generally, but SOFI stock is a worthy investment.
Gevo joins the Russell 3000 Index on June 28. The move is part of the index’s annual reconstitution. It should help lift GEVO stock.
These gold stocks have been killing it recently and present themselves as an excellent hedge for investors coping with inflation fears.
If you're bullish on renewable natural gas's role in the clean energy revolution, ignore its current meme status and take a position in CLNE stock if it dips after the social momentum fades.
Given that prices of rare earth metals should remain high in the long-term and its importance. Investors should consider MP stock.
Many trends were accelerated by the Covid-19 health crisis and have now become entrenched in our everyday lives. Looking forward, there are a number of companies that are at the forefront of these life-changing trends. And their stocks are worth buying and holding for the long-term. While no investor has a crystal ball, these four stocks are safe bets that investors can make to capitalize on the shifts taking place in society.
Investors in search of long-term growth are increasingly choosing biotech stocks like BNTX stock and MRNA stock for their portfolios.
A new short report from Hindenburg Research claims that a portion of DraftKings business comes from black markets. But we don't see any reason to freak out.
Zomedica is good value looks like it will go on the acquisition warpath. ZOM stock is worth between $1.11 and $1.61, or $1.36 on average, providing an average 20% ROI over 2 years.
BYND stock went nowhere for a full year, but it's poised for a breakout moment as Beyond Meat shows up in multiple world geographies.
NAKD stock is worth a look as Naked Brands continues to pivot into e-commerce and its shares are still cheap.
Searching for stocks to buy that could legitimately double before 2022? These seven are in position to do just that.
Meme stocks may appear random, but they are anything but... To drive the stock price to the moon, it takes certain characteristics...
With solid delivery growth and a key technology advantage, NIO stock is looking more and more like a frontrunner in the EV race.
ZM stock remains well off its 2020 highs, but with a hybrid future for many companies, don’t write off Zoom as a pandemic anomaly.
If you're looking to get on the ground-floor of "self-driving," consider ditching self-driving cars in favor of self-driving trucks.
FSR stock is a decent investment because Fisker has a unique upcoming electric vehicle that's already starting to impress consumers.
Growth stocks have been crushed over the past few months, but are bouncing back now. Let's look at 7 of the best to buy.